Pfizer begins study of oral drug for prevention of COVID-19

World4 minutes ago (Sep 27, 2021 07:58AM ET)

(C) Reuters. FILE PHOTO: Pfizer logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) -Pfizer Inc said on Monday it has started a mid-to-late-stage study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus.

The company and its rivals, including U.S.-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG (OTC:RHHVF), have been racing to develop the first antiviral pill for COVID-19.

Pfizer (NYSE:PFE) said it would study the drug, PF-07321332, in up to 2,660 healthy adult participants aged 18 and older who live in the same household as an individual with a confirmed symptomatic COVID-19 infection.

The trial would test PF-07321332 with a low dose of ritonavir, an older medication widely used in combination treatments for HIV infection.

Merck and partner Ridgeback Biotherapeutics said earlier this month they had begun enrolling patients in a late-stage trial of their experimental drug molnupiravir for prevention of COVID-19 infection.

Pfizer had also said earlier this month it started a mid-to-late-stage trial of PF-07321332 for the treatment of COVID-19 in non-hospitalized, symptomatic adult patients.

Pfizer begins study of oral drug for prevention of COVID-19

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

More from author

Subscribe

Related posts

Latest posts

Michigan judge tosses GM lawsuit against Fiat Chrysler

Stock Markets23 minutes ago (Oct 17, 2021 05:20PM ET) (C) Reuters. FILE PHOTO: The new GM logo is seen on the facade of the General...

Gangs expand territory as Haiti government struggles to stay in control

World40 minutes ago (Oct 17, 2021 03:50PM ET) (C) Reuters. FILE PHOTO: A general view of buildings in Port-au-Prince, is seen from the outskirts of...

A Sinister Six Movie Should Copy Spider-Man: No Way Home & Bring In Miles

Sony's upcoming Sinister Six movie should take some inspiration from Spider-Man: No Way Home and introduce a new version of Miles Morales. Sony has...

Categories

Want to stay up to date with the latest news?

We would love to hear from you! Please fill in your details and we will stay in touch. It's that simple!